Benzinga's Top Downgrades

By: via Benzinga
Analysts at William Blair downgraded Allergan (NYSE: AGN) from Outperform to Market Perform. The price target for Allergan is set to ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.